Cong Li
Qingdao University(CN)Academy of Medical Sciences(GB)Sun Yat-sen University(CN)Hangzhou Normal University(CN)Northwestern Polytechnical University(CN)Hunan Normal University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Peking Union Medical College Hospital(CN)Southern University of Science and Technology(CN)Third People's Hospital of Chengdu(CN)Chengdu Third People's Hospital(CN)Institute of Primate Research(KE)Fifth Affiliated Hospital of Sun Yat-sen University(CN)Federal State Budgetary Scientific Institution Research Institute of Medical Primatology(RU)Second Affiliated Hospital of Xi'an Jiaotong University(CN)Guangdong Academy of Medical Sciences(CN)Nanjing Medical University(CN)Ministry of Industry and Information Technology(CN)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Hepatocellular Carcinoma Treatment and Prognosis, Liver physiology and pathology, Berberine and alkaloids research, Gut microbiota and health
Most-Cited Works
- → Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins(2004)1,362 cited
- → Cell softness regulates tumorigenicity and stemness of cancer cells(2020)130 cited
- → Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases(2019)70 cited
- → Tumor-derived microparticles promote the progression of triple-negative breast cancer via PD-L1-associated immune suppression(2021)49 cited
- → The role and mechanism of transforming growth factor beta 3 in human myocardial infarction‐induced myocardial fibrosis(2019)47 cited
- → Dual‐Stimuli‐Responsive Gut Microbiota‐Targeting Berberine‐CS/PT‐NPs Improved Metabolic Status in Obese Hamsters(2019)46 cited